NEWLINK GENETICS CORPORATION
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Dec 26, 2017 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 246 Total Citation Count
- Mar 26, 2004 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9617272 Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolizationMar 10, 14Apr 11, 17[C07D]
9512158 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopesDec 17, 12Dec 06, 16[A61K, C07H]
9090643 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopesDec 17, 12Jul 28, 15[A61K, C07H]
8916169 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopesDec 17, 12Dec 23, 14[A61K, C07H]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0149,331 RHAMNOSE AND FORSSMAN CONJUGATED IMMUNOGENIC AGENTSAbandonedMay 03, 12Jun 13, 13[A61K]
2004/0191,873 Method for high throughput elucidation of transcriptional profiles and genome annotationAbandonedMar 26, 04Sep 30, 04[C12Q, C12P, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.